Stay updated on Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Pembrolizumab in RCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe Revision label on the page changed from v3.5.3 to v3.5.4, indicating a newer page version of the study listing rather than a change to the study details.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page’s display/release revision label was updated from v3.5.2 to v3.5.3, indicating a minor tooling or website update rather than a change to the study record information.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be an internal build update and does not change visible content on the page.SummaryDifference0.1%

- Check76 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.4.3 was added, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check112 days agoChange DetectedThe page shows a new revision tag (v3.4.2) and removal of a prior government funding notice; no changes to the study details, outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.